Disease Markers

Table of Contents

  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 2619828
  • - Research Article

Pathway Analysis Based on Attractor and Cross Talk in Colon Cancer

Yanxia Liu | Lin Wang | ... | Yufeng Cheng
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 8289293
  • - Research Article

The Effect of Poly(ADP-ribose) Polymerase-1 Gene 3′Untranslated Region Polymorphism in Colorectal Cancer Risk among Saudi Cohort

Abdullah M. Alhadheq | Jilani Purusottapatnam Shaik | ... | Narasimha Reddy Parine
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 3693096
  • - Research Article

Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer

Inessa Skrypkina | Liudmyla Tsyba | ... | Alla Rynditch
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 2832980
  • - Research Article

Identification of Differentially Expressed Kinase and Screening Potential Anticancer Drugs in Papillary Thyroid Carcinoma

Huairong Zhang | Bo Gao | Bingyin Shi
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 2436518
  • - Research Article

TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis

Fang Liu | Yuan He | ... | Wenhui Zhang
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 7648215
  • - Research Article

Increased Serum Level of MicroRNA-663 Is Correlated with Poor Prognosis of Patients with Nasopharyngeal Carcinoma

Shaoqiang Liang | Ning Zhang | ... | Tao Xun
  • Disease Markers -
  • Special Issue
  • - Volume 2016
  • - Article ID 3185232
  • - Research Article

Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease

Simona Mihai | Elena Codrici | ... | Cristiana Tanase
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 7475080
  • - Research Article

TaqI, FokI, and ApaI Polymorphisms in the Vitamin D Receptor in Behçet’s Disease in Turkish Population

Gaye Erten | Muhammed Kalkan | ... | Burcak Vural
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 4591910
  • - Research Article

Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis

Marine De Paoli | Selma Gogalic | ... | Christophe Marquette
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 7806438
  • - Research Article

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?

Hitoshi Suzuki | Landino Allegri | ... | Bruce A. Julian
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 2025418
  • - Research Article

Correlation of Serum β-Endorphin and the Quality of Life in Allergic Rhinitis

Jichao Sha | Cuida Meng | ... | Dongdong Zhu
  • Disease Markers -
  • Special Issue
  • - Volume 2016
  • - Article ID 9406319
  • - Review Article

CEACAM1: Expression and Role in Melanocyte Transformation

Gabriela Turcu | Roxana Ioana Nedelcu | ... | Sabina Andrada Zurac
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 5423043
  • - Research Article

The Role of Fecal Calprotectin in Evaluating Intestinal Involvement of Behçet’s Disease

Burak Özşeker | Cem Şahin | ... | Yusuf Bayraktar
  • Disease Markers -
  • Special Issue
  • - Volume 2016
  • - Article ID 4517492
  • - Review Article

From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers

Vlad Voiculescu | Bogdan Calenic | ... | Constantin Caruntu
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 6984270
  • - Research Article

miR-155 Inhibits Nucleus Pulposus Cells’ Degeneration through Targeting ERK 1/2

Dongping Ye | Libing Dai | ... | Weiguo Liang
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.